亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

武漢遠城科技發展有限公司集團總部  

精細化工,香精香料,食品添加劑,醫藥原料及中間體等產品

搜索
新聞中心
  • 暫無新聞
產品分類
聯系方式
  • 聯系人:錢鑫
  • 電話:027-50755969
  • 郵件:dhh04@ycphar.com
  • 傳真:027-68886696
  • QQ:2355327120
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 醋酸奧曲肽
醋酸奧曲肽
單價 1.00 / 千克對比
銷量 暫無
發貨 湖北武漢市付款后3天內
庫存 10000千克起訂1千克
品牌 南箭
含量 99%
過期 長期有效
更新 2015-10-06 09:06
 
詳細信息
 醋酸奧曲肽
中文同義詞: 醋酸奧曲肽;[R-(R^<*>^,R^<*>^)]-D-苯丙酰-L-半胱氨酰-L-苯丙酰-D-色胺酰-L-賴氨酰-1-蘇氨酰-N-[2-羥基-1-(羥基甲基)丙基]-L-蘇氨酰胺環(2→7)二硫化物;醋酸奧曲肽 OCTREOTIDEACETATE;醋酸奧曲肽 83150-76-9
英文名稱: Octreotide acetate
英文同義詞: DARAMONOL;L-cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-(2-hydroxy-1-(hydroxymethyl) propyl)-cyclic (2->7)-disulfide, (R-(R*,R*));ctreotide;Ocetreotide, Acetate;L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl-, cyclic (2?7)-disulfide;OXTREOTIDE;[R-(R*,R*)]-D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[2-hydroxy-1-(hydroxy-methyl)propyl]-cysteinamide cyclic(2->7)-disulfide;Octreotide acetate
CAS號: 83150-76-9
分子式: C49H66N10O10S2
分子量: 1019.24
用途 作用和天然內源性生長抑素類似,作用較強而持久。用于緩解由胃、腸、胰內分泌系統腫瘤或類癌腫瘤所產生的癥狀,對腫瘤的治療無效。
含量:98%
包裝:1kg/鋁箔
©2025 武漢遠城科技發展有限公司集團總部 版權所有   技術支持:化工網   訪問量:4726  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |